1
|
Hirsch FR, Suda K, Wiens J and Bunn PA Jr:
New and emerging targeted treatments in advanced non-small-cell
lung cancer. Lancet. 388:1012–1024. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Maas KW, El Sharouni SY, Smit EF and
Schramel FM: Sequencing chemotherapy, radiotherapy and surgery in
combined modality treatment of stage III nonsmall cell lung cancer.
Curr Opin Pulm Med. 13:297–304. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Richard PJ and Rengan R: Oligometastatic
non-small-cell lung cancer: Current treatment strategies. Lung
Cancer (Auckl). 7:129–140. 2016.PubMed/NCBI
|
4
|
Rosell R and Karachaliou N: Lung cancer in
2014: Optimizing lung cancer treatment approaches. Nat Rev Clin
Oncol. 12:75–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Woods NT, Monteiro AN, Thompson ZJ,
Amankwah EK, Naas N, Haura EB, Beg AA and Schabath MB: Interleukin
polymorphisms associated with overall survival, disease-free
survival, and recurrence in non-small cell lung cancer patients.
Mol Carcinog. 54 Suppl 1:E172–E184. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Serghiou S, Kyriakopoulou A and Ioannidis
JP: Long noncoding RNAs as novel predictors of survival in human
cancer: A systematic review and meta-analysis. Mol Cancer.
15:502016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Weng M, Wu D, Yang C, Peng H, Wang G, Wang
T and Li X: Noncoding RNAs in the development, diagnosis, and
prognosis of colorectal cancer. Transl Res. 181:108–120. 2016.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Borensztein M, Syx L, Ancelin K,
Diabangouaya P, Picard C, Liu T, Liang JB, Vassilev I, Galupa R and
Servant N: Xist-dependent imprinted X inactivation and the early
developmental consequences of its failure. Nat Struct Mol Biol.
24:226–233. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Guo JY and White E: Autophagy, metabolism,
and cancer. Cold Spring Harb Symp Quant Biol. 81:73–78. 2017.
View Article : Google Scholar :
|
11
|
Li D, Liu X, Zhou J, Hu J, Zhang D, Liu J,
Qiao Y and Zhan Q: LncRNA HULC modulates the phosphorylation of
YB-1 through serving as a scaffold of ERK and YB-1 to enhance
hepatocarcinogenesis. Hepatology. 65:1612–1627. 2016. View Article : Google Scholar
|
12
|
Li L, Chen H, Gao Y, Wang YW, Zhang GQ,
Pan SH, Ji L, Kong R, Wang G, Jia YH, et al: Long noncoding RNA
MALAT1 promotes aggressive pancreatic cancer proliferation and
metastasis via the stimulation of autophagy. Mol Cancer Ther.
15:2232–2243. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Liu Z, Wei X, Zhang A, Li C, Bai J and
Dong J: Long non-coding RNA HNF1A-AS1 functioned as an oncogene and
autophagy promoter in hepatocellular carcinoma through sponging
hsa-miR-30b-5p. Biochem Biophys Res Commun. 473:1268–1275. 2016.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Xue X, Yang YA, Zhang A, Fong KW, Kim J,
Song B, Li S, Zhao JC and Yu J: LncRNA HOTAIR enhances ER signaling
and confers tamoxifen resistance in breast cancer. Oncogene.
35:2746–2755. 2016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Shi SJ, Wang LJ, Yu B, Li YH, Jin Y and
Bai XZ: LncRNA-ATB promotes trastuzumab resistance and
invasion-metastasis cascade in breast cancer. Oncotarget.
6:11652–11663. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhang XW, Bu P, Liu L, Zhang XZ and Li J:
Overexpression of long non-coding RNA PVT1 in gastric cancer cells
promotes the development of multidrug resistance. Biochem Biophys
Res Commun. 462:227–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W,
De W, Wang Z and Wang R: The long noncoding RNA HOTAIR contributes
to cisplatin resistance of human lung adenocarcinoma cells via
downregualtion of p21WAF1/CIP1 expression. PLoS One.
8:e772932013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P,
Lu B, Liu G and Wang Z: The long noncoding RNA MEG3 contributes to
cisplatin resistance of human lung adenocarcinoma. PLoS One.
10:e01145862015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Tantai J, Hu D, Yang Y and Geng J:
Combined identification of long non-coding RNA XIST and HIF1A-AS1
in serum as an effective screening for non-small cell lung cancer.
Int J Clin Exp Pathol. 8:7887–7895. 2015.PubMed/NCBI
|
20
|
Hu X and Xuan Y: Bypassing cancer drug
resistance by activating multiple death pathways - a proposal from
the study of circumventing cancer drug resistance by induction of
necroptosis. Cancer Lett. 259:127–137. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Levine B and Klionsky DJ: Development by
self-digestion: Molecular mechanisms and biological functions of
autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
22
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View
Article : Google Scholar : PubMed/NCBI
|
24
|
Ferraresi A, Phadngam S, Morani F, Galetto
A, Alabiso O, Chiorino G and Isidoro C: Resveratrol inhibits
IL-6-induced ovarian cancer cell migration through epigenetic
up-regulation of autophagy. Mol Carcinog. 56:1164–1181. 2017.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Xiong H, Ni Z, He J, Jiang S, Li X, He J,
Gong W, Zheng L, Chen S, Li B, et al: LncRNA HULC triggers
autophagy via stabilizing Sirt1 and attenuates the chemosensitivity
of HCC cells. Oncogene. 36:3528–3540. 2017. View Article : Google Scholar : PubMed/NCBI
|
26
|
Ma L, Zhou Y, Luo X, Gao H, Deng X and
Jiang Y: Long non-coding RNA XIST promotes cell growth and invasion
through regulating miR-497/MACC1 axis in gastric cancer.
Oncotarget. 8:4125–4135. 2017.PubMed/NCBI
|
27
|
Yao Y, Ma J, Xue Y, Wang P, Li Z, Liu J,
Chen L, Xi Z, Teng H, Wang Z, et al: Knockdown of long non-coding
RNA XIST exerts tumor-suppressive functions in human glioblastoma
stem cells by up-regulating miR-152. Cancer Lett. 359:75–86. 2015.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Du Y, Kong G, You X, Zhang S, Zhang T, Gao
Y, Ye L and Zhang X: Elevation of highly up-regulated in liver
cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell
proliferation via down-regulating p18. J Biol Chem.
287:26302–26311. 2012. View Article : Google Scholar : PubMed/NCBI
|
31
|
Hafner SJ, Talvard TG and Lund AH: Long
noncoding RNAs in normal and pathological pluripotency. Semin Cell
Dev Biol. 2016.PubMed/NCBI
|
32
|
Li SP, Xu HX, Yu Y, He JD, Wang Z, Xu YJ,
Wang CY, Zhang HM, Zhang RX, Zhang JJ, et al: LncRNA HULC enhances
epithelial-mesenchymal transition to promote tumorigenesis and
metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1
signaling pathway. Oncotarget. 7:42431–42446. 2016.PubMed/NCBI
|
33
|
Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu
Y, Feng Y, Liu H, Fei B, Mao Y, et al: LncRNA-UCA1 enhances cell
proliferation and 5-fluorouracil resistance in colorectal cancer by
inhibiting miR-204-5p. Sci Rep. 6:238922016. View Article : Google Scholar : PubMed/NCBI
|
34
|
Lee H, Kim C, Ku JL, Kim W, Yoon SK, Kuh
HJ, Lee JH, Nam SW and Lee EK: A long non-coding RNA snaR
contributes to 5-fluorouracil resistance in human colon cancer
cells. Mol Cells. 37:540–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
35
|
Özeş AR, Miller DF, Özeş ON, Fang F, Liu
Y, Matei D, Huang T and Nephew KP: NF-κB-HOTAIR axis links DNA
damage response, chemoresistance and cellular senescence in ovarian
cancer. Oncogene. 35:5350–5361. 2016. View Article : Google Scholar : PubMed/NCBI
|
36
|
Takahashi K, Yan IK, Wood J, Haga H and
Patel T: Involvement of extracellular vesicle long noncoding RNA
(linc-VLDLR) in tumor cell responses to chemotherapy. Mol Cancer
Res. 12:1377–1387. 2014. View Article : Google Scholar : PubMed/NCBI
|
37
|
Wang Y, Zhang D, Wu K, Zhao Q, Nie Y and
Fan D: Long noncoding RNA MRUL promotes ABCB1 expression in
multidrug-resistant gastric cancer cell sublines. Mol Cell Biol.
34:3182–3193. 2014. View Article : Google Scholar : PubMed/NCBI
|
38
|
Jing Z, Han W, Sui X, Xie J and Pan H:
Interaction of autophagy with microRNAs and their potential
therapeutic implications in human cancers. Cancer Lett.
356:332–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
39
|
Liu JJ, Lin M, Yu JY, Liu B and Bao JK:
Targeting apoptotic and autophagic pathways for cancer
therapeutics. Cancer Lett. 300:105–114. 2011. View Article : Google Scholar : PubMed/NCBI
|